205 related articles for article (PubMed ID: 36320118)
1. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
Albrecht LJ; Höwner A; Griewank K; Lueong SS; von Neuhoff N; Horn PA; Sucker A; Paschen A; Livingstone E; Ugurel S; Zimmer L; Horn S; Siveke JT; Schadendorf D; Váraljai R; Roesch A
Clin Transl Med; 2022 Nov; 12(11):e1090. PubMed ID: 36320118
[TBL] [Abstract][Full Text] [Related]
2. The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.
Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Siveke JT; Schuler M; Lueong SS
Thorac Cancer; 2022 Aug; 13(15):2180-2191. PubMed ID: 35708207
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection.
Ning C; Cai P; Liu X; Li G; Bao P; Yan L; Ning M; Tang K; Luo Y; Guo H; Wang Y; Wang Z; Chen L; Lu ZJ; Yin J
EBioMedicine; 2023 Jul; 93():104645. PubMed ID: 37315449
[TBL] [Abstract][Full Text] [Related]
4. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
[TBL] [Abstract][Full Text] [Related]
5. Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.
Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA
Eur Urol; 2020 Aug; 78(2):173-180. PubMed ID: 32487321
[TBL] [Abstract][Full Text] [Related]
6. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
[TBL] [Abstract][Full Text] [Related]
7. The predictive and prognostic significance of cell-free DNA concentration in melanoma.
Váraljai R; Elouali S; Lueong SS; Wistuba-Hamprecht K; Seremet T; Siveke JT; Becker JC; Sucker A; Paschen A; Horn PA; Neyns B; Weide B; Schadendorf D; Roesch A
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):387-395. PubMed ID: 32569440
[TBL] [Abstract][Full Text] [Related]
8. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
9. Cell-free RNA for the liquid biopsy of gastrointestinal cancer.
Xing S; Zhu Y; You Y; Wang S; Wang H; Ning M; Jin H; Liu Z; Zhang X; Yu C; Lu ZJ
Wiley Interdiscip Rev RNA; 2023; 14(5):e1791. PubMed ID: 37086051
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Effects of Storage Conditions on Multiple Cell-Free RNAs in Plasma by High-Throughput Sequencing.
Sun J; Yang X; Wang T; Xing Y; Chen H; Zhu S; Zeng J; Zhou Q; Chen F; Zhang X; Wang WJ
Biopreserv Biobank; 2023 Jun; 21(3):242-254. PubMed ID: 36006659
[No Abstract] [Full Text] [Related]
11. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
[TBL] [Abstract][Full Text] [Related]
12. Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples.
Wagner JT; Kim HJ; Johnson-Camacho KC; Kelley T; Newell LF; Spellman PT; Ngo TTM
Sci Rep; 2020 Oct; 10(1):16456. PubMed ID: 33020547
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free RNA Sequencing from Biofluid Samples.
Zhang L; Liu X; Wang C; Li X; Tian G; Wang W
Methods Mol Biol; 2023; 2695():9-25. PubMed ID: 37450109
[TBL] [Abstract][Full Text] [Related]
15. Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer.
Metzenmacher M; Váraljai R; Hegedüs B; Cima I; Forster J; Schramm A; Scheffler B; Horn PA; Klein CA; Szarvas T; Reis H; Bielefeld N; Roesch A; Aigner C; Kunzmann V; Wiesweg M; Siveke JT; Schuler M; Lueong SS
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033141
[TBL] [Abstract][Full Text] [Related]
16. Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer.
Safrastyan A; Zu Siederdissen CH; Wollny D
Hum Genomics; 2023 Oct; 17(1):90. PubMed ID: 37798661
[TBL] [Abstract][Full Text] [Related]
17. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
Albitar M; Zhang H; Charifa A; Ip A; Ma W; McCloskey J; Donato M; Siegel D; Waintraub S; Gutierrez M; Pecora A; Goy A
Heliyon; 2023 May; 9(5):e16261. PubMed ID: 37251903
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Dummer R; Brase JC; Garrett J; Campbell CD; Gasal E; Squires M; Gusenleitner D; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Flaherty K; Larkin J; Robert C; Kefford R; Kirkwood JM; Hauschild A; Schadendorf D; Long GV
Lancet Oncol; 2020 Mar; 21(3):358-372. PubMed ID: 32007138
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection.
Larson MH; Pan W; Kim HJ; Mauntz RE; Stuart SM; Pimentel M; Zhou Y; Knudsgaard P; Demas V; Aravanis AM; Jamshidi A
Nat Commun; 2021 Apr; 12(1):2357. PubMed ID: 33883548
[TBL] [Abstract][Full Text] [Related]
20. Plasma circulating cell free messenger RNA as a potential biomarker of melanoma.
Ita MI; Wang JH; Fanning N; Kaar G; Lim C; Redmond HP
Acta Oncol; 2021 Sep; 60(9):1201-1209. PubMed ID: 34086522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
